FIELD: medicine; gastroenterology.
SUBSTANCE: H.pylori occurrence in organism is detected by any common methods and in case this agent is detected, sialic acid content is detected in oral fluid. Low content of sialic acids in oral fluid - less than 5.0 mg/l provides appointment of antihelicobacter therapy, and at values - more than 5.0 mg/l the given therapy is not appointed.
EFFECT: method application provides more reasonable appointment of helicobacter therapy for treatment of dyspepsia syndrome, reduction of medicinal load, reduction of hospitalisation time.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CHRONIC GASTRODUODENITIS ASSOCIATED WITH INFECTION CAUSED BY BACTERIA Helicobacter pylori IN ALLERGIC DISEASES | 2011 |
|
RU2472498C1 |
| METHOD FOR INDIVIDUALIZATION OF ANTI-HELICOBACTER THERAPY IN CHILDREN IN CASE OF FUNCTIONAL DYSPEPSIA | 2005 |
|
RU2275912C1 |
| DIAGNOSTIC TECHNIQUE FOR DEGREE OF ACTIVITY OF ANTRAL HELICOBACTER-ASSOCIATED GASTRITIS IN PATIENTS WITH BRONCHIAL ASTHMA | 2009 |
|
RU2394499C1 |
| METHOD FOR TREATMENT OF EXCESS BACTERIAL GROWTH IN SMALL INTESTINE IN PATIENTS WITH TYPE 2 DIABETES IN COMBINATION WITH GASTRODUODENAL HELICOBACTERIOSIS | 2017 |
|
RU2674447C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF EPIGASTRAL PAIN SYNDROME | 2001 |
|
RU2226070C2 |
| MEANS EVALUATING THE DYNAMICS OF THE CHILDREN'S NON-ULCER DYSPEPSIA COURSE | 2008 |
|
RU2442538C2 |
| METHOD FOR TREATING HELICOBACTER-ASSOCIATED CHRONIC DUODENAL ULCER | 2003 |
|
RU2252777C2 |
| METHOD FOR DETERMINING HELICOBACTER PYLORI-ASSOCIATED INTRAGASTRAL UREASE ACTIVITY | 2001 |
|
RU2189591C1 |
| IMMUNE DIAGNOSTIC TECHNIQUE FOR DISEASES CAUSED BY HELICOBACTER PYLORI INFECTION | 2014 |
|
RU2572717C1 |
| MEDICINAL AGENT, PHARMACEUTICAL COMPOSITION, HELICOBACTER PYLORI GROWTH INHIBITOR AND METHOD OF ANTIHELICOBACTERY THERAPY | 2007 |
|
RU2367458C1 |
